Biotech cools off in August as capital markets weaken

September 01, 2010

› Learn more

Biotech gets hot in July

August 02, 2010

› Learn more

Shawn Cross appointed CEO of Burrill Merchant Banking Group

July 28, 2010

› Learn more

Biotech hit hard in second quarter

July 01, 2010

› Learn more

Biotech Pulled Down by Capital Markets in May

June 02, 2010

› Learn more

Biotech Posts Weak Performance in April

May 04, 2010

› Learn more

Biotech posts strong first quarter gain

Industry benefits from healthcare reform and robust general markets

April 01, 2010

› Learn more

Biotech posts gain in February as broader markets strengthen

March 03, 2010

› Learn more

Biotech holds steady in January as broader markets head south

February 01, 2010

› Learn more

Biotech Closes the Year on an Upswing

January 04, 2010

› Learn more

Biotech gets back on track in November

December 01, 2009

› Learn more

Biotech takes it on the chin in October

November 02, 2009

› Learn more

Burrill & Company and WR Hambrecht + Co to collaborate on OpenIPO® transactions

Joint venture will focus on select healthcare companies

October 09, 2009

› Learn more

Biotech gets on a roll in third quarter

October 01, 2009

› Learn more

FDA Commissioner Dr. Margaret Hamburg headlines at the Burrill Annual Personalized Medicine Meeting

September 16, 2009

› Learn more

Biotech cools off in August but capital markets remain positive

September 01, 2009

› Learn more

Biotech hot in July driven by positive drug data and acquisitions

August 03, 2009

› Learn more

NewBridge Pharmaceuticals Announces Licensing of Pylera® for Middle East, Africa, Turkey & Caspian Region

July 22, 2009

› Learn more

Burrill Merchant Banking Advises Pfizer Inc. on Dermatology Portfolio Divestment

July 16, 2009

› Learn more

Burrill & Company invests in Taiwan Liposome Company

July 07, 2009

› Learn more

Biotech buoyed by strong capital market performance in second quarter

July 01, 2009

› Learn more

Shawn Cross Joins Burrill Merchant Banking

June 16, 2009

› Learn more

Biotech shows glimmer of an upward trend

June 01, 2009

› Learn more

Biotech drops on weaker first quarter drug sales, but broader markets remain on a roll

May 01, 2009

› Learn more

Burrill & Company announces promotions

April 10, 2009

› Learn more

Biotech finishes down after turbulent quarter

April 01, 2009

› Learn more

Burrill Merchant Banking Advises Adlyfe on Alzheimer’s Biomarker Partnership with Wyeth

March 17, 2009

› Learn more

Elk Run Developers Announce Partnership With Leading Life Sciences Firm

March 12, 2009

› Learn more

R&D Spending by U.S. Biopharmaceutical Companies increases 3 percent in 2008

March 10, 2009

› Learn more

Biotech takes a hit following the Administration’s budget plans for healthcare

March 02, 2009

› Learn more

Biotech Industry Turns a Profit for the First Time, But Milestone Overshadowed as Companies Struggle for Survival, Report Finds

February 25, 2009

› Learn more

Biotech holds steady as broader markets tumble

February 02, 2009

› Learn more

Biotech holds up well in the face of financial crisis and market turmoil

January 02, 2009

› Learn more

G. Steven Burrill predicts what’s ahead for biotech in 2009

January 02, 2009

› Learn more

Biotech’s small cap companies restructuring to conserve cash

December 01, 2008

› Learn more

Biotechs claw for their lifeblood - financing

November 17, 2008

› Learn more

Biotech Visionary, G. Steven Burrill receives DiNA

November 14, 2008

› Learn more

Redpoint Bio Retains Burrill & Co. to Advise on Strategic Alternatives

November 12, 2008

› Learn more

Biotech reels from one of the worst months on record for the capital markets

November 03, 2008

› Learn more

Victor A. Hebert joins Burrill & Company

October 10, 2008

› Learn more

Biotech takes a beating in market meltdown

October 01, 2008

› Learn more

Burrill Merchant Banking advises Mitsubishi Tanabe Pharma Corporation on transactions with Cytochroma Inc.

September 08, 2008

› Learn more

Biotech drops back to earth in August

September 03, 2008

› Learn more

Biotech red hot in July as potential blockbuster M&A deals awake investors from their summer slumber

August 01, 2008

› Learn more

Biotech remains upbeat in wake of market turmoil

July 01, 2008

› Learn more

Genetic test industry faces tough challenges with consumers, survey finds

June 17, 2008

› Learn more

G. Steven Burrill Presents the 'State-of-the-Industry' at BIO 2008

June 17, 2008

› Learn more

Biotech outperforms market in May

June 02, 2008

› Learn more

Biotech Treads Water in April

May 01, 2008

› Learn more

Burrill Opens Registration for its 3rd Annual India Life Sciences Meeting

April 25, 2008

› Learn more

Burrill Opens Registration for its 4th annual Burrill China Life Sciences Meeting

April 25, 2008

› Learn more

Personalized medicine is having a dramatic effect on healthcare delivery

April 21, 2008

› Learn more

Seventh Annual Aged To Perfection Gala To Attract Wine Lovers of San Francisco

April 16, 2008

› Learn more

Biotech 2008 Teleconference with G. Steven Burrill

April 15, 2008

› Learn more

Biotech avoids fall out from tough quarter for capital markets

April 01, 2008

› Learn more

Biotech drops amid tough markets in February

March 03, 2008

› Learn more

January market jitters fails to derail biotech

February 01, 2008

› Learn more

Biotech has positive year despite weak fourth quarter performance

January 02, 2008

› Learn more

Biotech Hit by Market Jitters in July

August 01, 2007

› Learn more

Biotech Remained Flat in May

June 06, 2007

› Learn more

Biotech Establishes New Record for Market Cap in April

May 01, 2007

› Learn more

Dr. Ganesh M. Kishore joins Burrill & Company

April 20, 2007

› Learn more

Burrill Merchant Banking Advises QLT USA on divestment of QLT USA, INC.'s Generic Dermatology and Manufacturing Business

April 12, 2007

› Learn more

Stem Cell Summit Launched

March 23, 2007

› Learn more

Biopharmaceutical Industry Research & Development Tops $55 Billion In 2006

February 12, 2007

› Learn more

Randy Guggenheimer Joins Burrill Merchant Banking

January 04, 2007

› Learn more

Anton Gueth Joins Burrill Merchant Banking

December 06, 2006

› Learn more

Burrill Merchant Banking Advises FAES Farma on Phase III Licensing Agreement

November 29, 2006

› Learn more

Burrill Merchant Banking Newsletter Q3, 2006

November 10, 2006

› Learn more

Mohan S. Iyer Joins Burrill & Company's Merchant Banking Group

April 24, 2006

› Learn more

A Changing Prescription for Biotechnology

April 11, 2006

› Learn more

Burrill & Company and Beijing Pharmaceutical Group Form Strategic Partnership to Capture Cross-Pacific Life Sciences Opportunities

April 11, 2006

› Learn more

Biopharmaceutical Industry Research & Development Tops $51 Billion In 2005

March 07, 2006

› Learn more

Biotech’s Mid Caps Post Solid Gain in February

March 03, 2006

› Learn more

Burrill's Biotech Outlook For 2006 ...and A Look Back At 2005

December 23, 2005

› Learn more

Burrill & Company Advises Danisco A/S on Divestiture of Genencor Oncology Program

November 09, 2005

› Learn more

Midwest Will Be Next Biotech Hotbed

September 28, 2005

› Learn more

Hal Gerber, M.D Joins Burrill & Company’s Merchant Banking Group To Further Expand M&A Services

August 01, 2005

› Learn more

Burrill & Company launches China Access Forums to provide gateway for North America Life Sciences companies to access China opportunities

March 24, 2005

› Learn more

Biopharmaceutical Industry Research & Development Tops $49 Billion In 2004

March 17, 2005

› Learn more

Jonathan Wang Joins Burrill & Company to Focus on Greater China Opportunities

February 02, 2005

› Learn more

Burrill & Company Announces the Life Sciences Capital Fund III

January 07, 2005

› Learn more

Biotech Recognized as One of San Francisco Mayor Gavin Newsom's First Year Accomplishments

January 07, 2005

› Learn more

Burrill & Company's Merchant Banking Practice Announces Increasing Spin-Out Activity From Pharmaceutical Companies

January 07, 2005

› Learn more

Burrill & Company Announces Promotions and Organizational Changes to Reflect the Growth of its Business

January 05, 2005

› Learn more

Burrill's Biotech Outlook for 2005

December 22, 2004

› Learn more

Biotech Honors The Best of 2004

October 14, 2004

› Learn more

20,000 Biotech Executives Gather at Bio in San Francisco Biotech on Track for Success

June 08, 2004

› Learn more

Burrill & Company Announces Closing of Burrill Life Sciences Capital Fund

January 12, 2004

› Learn more

Mitsubishi Corporation Invests in Burrill Life Sciences Capital Fund

September 17, 2003

› Learn more

Biotech is Back

June 24, 2003

› Learn more

A Year of Revaluation and Restructuring for Biotech

May 09, 2003

› Learn more

Biotech Endures Looking Back at 2002 and Ahead to 2003…

December 12, 2002

› Learn more

James Watson Joins Burrill & Company to Focus on its Strategic Partnering Services

November 25, 2002

› Learn more

G. Steven Burrill is Recognized as Biotech Investment Visionary by Scientific American

November 20, 2002

› Learn more

Novel Alliance to Promote Biotech Strategic Partnerships with Israeli Companies

October 07, 2002

› Learn more

Burrill & Company and Biostreet Join Forces

January 02, 2002

› Learn more

Biotech Recognizes the Year's Best

October 11, 2001

› Learn more